Roland Magnusson/iStock Editorial via Getty Images
AstraZeneca (AZN) posted stronger-than-expected Q3 results, fueled by continued strength in its oncology portfolio. The U.K. drugmaker reported adjusted EPS of $2.38, well above the $1.13 consensus, while revenue rose 11.9% year-over-year to $15.19B, topping estimates by $420M.
Oncology product sales
The U.S. struck Iran on Friday in response to a drone attack a day earlier on a cargo ship in...
Trump says US will not change foundational motto, "In God We Trust," at the Faith and Freedom Coalition's Road to...
Jun 26, 2026, 4:39 PM ETS&P 500 Index (SP500)NFLX, AAPL, XLV, XLF, XLI, XLK, XLY, AMZN, MSFT, GS, STX, WDC,...
Red Lobsters’ infamous $20 “Ultimate Endless Shrimp” promotion nearly sank the restaurant chain, now shareholders are alleging the promotion was...
Wall Street ended lower on Friday, with a steep drop in AI-related chip stocks and sharp gains in Moderna and...
OpenAI is staggering the rollout of its newest and most powerful AI model after a request from the Trump administration....
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
-1024x683.jpg "Florida Roads Become a Battleground for Illegal Immigration")
